share_log

This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

这位百思买分析师看好市场;以下是周一的五个顶级升级方案
Benzinga ·  06/17 09:51

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

顶尖华尔街分析师改变对这些顶级股票的前景看法。如需全面了解所有分析师评级的变化,包括升级、降级和启动,请参阅我们的分析师评级页面。

  • Goldman Sachs analyst Susan Maklari upgraded the rating for Toll Brothers, Inc. (NYSE:TOL) from Sell to Neutral, while raising the price target from $112 to $124. Toll Brothers shares fell 1.2% to close at $119.32 on Friday. See how other analysts view this stock.
  • Piper Sandler analyst Edward Tenthoff upgraded Fate Therapeutics, Inc. (NASDAQ:FATE) from Neutral to Overweight and booted the price target from $4 to $6. Fate Therapeutics shares fell 4% to settle at $3.61 on Friday. See how other analysts view this stock.
  • B of A Securities analyst George Staphos upgraded the rating for Greif, Inc. (NYSE:GEF) from Neutral to Buy, while increasing the price target from $76 to $77. Greif shares fell 0.7% to settle at $60.73 on Friday. See how other analysts view this stock. See how other analysts view this stock.
  • Truist Securities analyst Bill Chappell upgraded Keurig Dr Pepper Inc. (NASDAQ:KDP) from Sell to Hold and boosted the price target from $27 to $34. Keurig Dr Pepper shares fell 0.1% to close at $34.04 on Friday. See how other analysts view this stock.
  • UBS analyst Michael Lasser upgraded the rating for Best Buy Co., Inc. (NYSE:BBY) from Neutral to Buy, while raising the price target from $85 to $106. Best Buy shares fell 0.6% to settle at $87.21 on Friday. See how other analysts view this stock.
  • 高盛的分析师Susan Maklari将Toll Brothers公司(NYSE:TOL)的评级从卖出升级到中立,将价格目标从112美元升至124美元。周五,Toll Brothers的股价下跌1.2%,收盘价为119.32美元。请查看其他分析师对这支股票的看法。
  • Piper Sandler的分析师Edward Tenthoff将Fate Therapeutics公司(NASDAQ:FATE)的评级从中立升级至超额表现,并将价格目标从4美元提高至6美元。周五,Fate Therapeutics的股价下跌4%,收于3.61美元。请查看其他分析师对这支股票的看法。
  • B of A Securities的分析师George Staphos将Greif公司(NYSE:GEF)的评级从中立升级至买入,并将价格目标从76美元增加至77美元。周五,Greif的股价下跌0.7%,收盘价为60.73美元。请查看其他分析师对这支股票的看法。
  • Truist Securities的分析师Bill Chappell将Keurig Dr Pepper公司(NASDAQ:KDP)的评级从卖出升级到持有,并将价格目标从27美元提高至34美元。周五,Keurig Dr Pepper的股价下跌0.1%,收盘价为34.04美元。请查看其他分析师对这支股票的看法。
  • UBS的分析师Michael Lasser将Best Buy公司(NYSE:BBY)的评级从中立升级到买入,并将价格目标从85美元提高至106美元。周五,百思买的股价下跌0.6%,收盘价为87.21美元。请查看其他分析师对这支股票的看法。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发